Nature Medicine, Published online: 21 October 2025; doi:10.1038/s41591-025-03969-0
In a phase 1 trial, intramuscular injection of synthetic plasmid DNA encoding monoclonal antibodies against SARS-CoV-2 was safe and well tolerated and did not elicit antidrug antibodies.
